Sleep disordered breathing in chronic heart failure

Heart Failure Reviews

Volumn 14, Issue 2, 2009, Pages 89-99

  Ng, Austin Chin Chwan ^a   Freedman, Saul Benedict ^a  

^a University of Sydney   (Australia)

Author keywords

Cardiovascular; Chronic heart failure; Sleep disordered breathing

Indexed keywords

ACETAZOLAMIDE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; NORADRENALIN; OXYGEN; THEOPHYLLINE;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROGNOSIS; QUESTIONNAIRE; SLEEP DISORDERED BREATHING;

CHRONIC DISEASE; COMORBIDITY; HEART FAILURE; HUMANS; POLYSOMNOGRAPHY; PREVALENCE; PROGNOSIS; SLEEP APNEA SYNDROMES; SLEEP APNEA, CENTRAL;

EID: 63749091649     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-008-9096-8     Document Type: Article

References (112)

1. American Heart Association. Heart disease and stroke statistics - 2005 update. Dallas, Texas: American Heart Association 2005
2. Hobbs RE (2004) Guidelines for the diagnosis and management of heart failure. Am J Ther 11:467-472. doi: 10.1097/01.mjt.0000127150.21184.01
3. American Academy of Sleep Medicine task force (1999) Sleep-related breathing disorders in adults. Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667-689
4. Javaheri S, Parker TJ, Liming JD et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97:2154-2159
5. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101-1106
6. Tkacova R, Niroumand M, Lorenzi-Filho G, Bradley TD (2001) Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 103:238-243
7. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A (1998) Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157:144-148
8. Shahar E, Whitney CW, Redline S et al (2001) Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19-25
9. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034-2041. doi: 10.1056/NEJMoa043104
10. Mansfield D, Kaye DM, Brunner La Rocca H, Solin P, Esler MD, Naughton MT (2003) Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 107:1396-1400. doi: 10.1161/01.CIR.0000056520.17353.4F
11. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230-1235. doi: 10.1056/NEJM199304293281704
12. Lanfranchi PA, Braghiroli A, Bosimini E et al (1999) Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99:1435-1440
13. Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164:2147-2165
14. Bradley TD, Logan AG, Kimoff RJ et al (2005) Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353:2025-2033. doi: 10.1056/NEJMoa051001
15. Staats BA, Bonekat HW, Harris CD, Offord KP (1984) Chest wall motion in sleep apnea. Am Rev Respir Dis 130:59-63
16. Littner MR, Kushida C, Wise M et al (2005) Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28:113-121
17. Johns MW (1991) A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 14:540-545
18. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485-491
19. Maislin G, Pack AI, Kribbs NB et al (1995) A survey screen for prediction of apnea. Sleep 18:158-166
20. Brostrom A, Stromberg A, Dahlstrom U, Fridlund B (2004) Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs 19:234-242
21. Arzt M, Floras JS, Logan AG et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: A post hoc analysis of the Canadian continuous positive airway pressure for patients with central sleep apnea and heart failure trial (CANPAP). Circulation 115:3173-3180. doi: 10.1161/CIRCULATIONAHA.106.683482
22. Chesson AL Jr, Berry RB, Pack A (2003) Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 26:907-913
23. American Thoracic Society/American College of Chest Physicians/American Academy of Sleep Medicine Taskforce Steering Committee (2004) Executive summary on the systematic review and practice parameters for portable monitoring in the investigation of suspected sleep apnea in adults. Am J Respir Crit Care Med 169:1160-1163. doi: 10.1164/rccm.169.1160
24. Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian A (1984) Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet 1:126-131. doi: 10.1016/S0140-6736(84)90062-X
25. Roche F, Pichot V, Sforza E et al (2003) Predicting sleep apnoea syndrome from heart period: A time-frequency wavelet analysis. Eur Respir J 22:937-942
26. Tateishi O, Shouda T, Sakai T, Honda Y, Mochizuki S, Machida K (2003) Apnea-related heart rate variability in congestive heart failure patients. Clin Exp Hypertens 25:183-189. doi: 10.1081/CEH-120019150
27. Leung RS, Floras JS, Lorenzi-Filho G, Rankin F, Picton P, Bradley TD (2003) Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. Am J Respir Crit Care Med 167:1534-1539. doi: 10.1164/rccm.200208-793OC
28. Leung RS, Bowman ME, Diep TM, Lorenzi-Filho G, Floras JS, Bradley TD (2005) Influence of Cheyne-Stokes respiration on ventricular response to atrial fibrillation in heart failure. J Appl Physiol 99:1689-1696. doi: 10.1152/japplphysiol.00027.2005
29. Penzel T (2003) Is heart rate variability the simple solution to diagnose sleep apnoea? Eur Respir J 22:870-871
30. Rosenberg P, Yancy CW (2000) Noninvasive assessment of hemodynamics: An emphasis on bioimpedance cardiography. Curr Opin Cardiol 15:151-155. doi: 10.1097/00001573-200005000-00005
31. Yasuda Y, Umezu A, Horihata S, Yamamoto K, Miki R, Koike S (2005) Modified thoracic impedance plethysmography to monitor sleep apnea syndromes. Sleep Med 6:215-224. doi: 10.1016/j.sleep.2004.09.002
32. Scharf C, Cho YK, Bloch KE et al (2004) Diagnosis of sleep-related breathing disorders by visual analysis of transthoracic impedance signals in pacemakers. Circulation 110:2562-2567. doi: 10.1161/ 01.CIR.0000145540.36097.EB
33. Bixler EO, Vgontzas AN, Lin HM et al (2001) Prevalence of sleep-disordered breathing in women: Effects of gender. Am J Respir Crit Care Med 163:608-613
34. Young T, Shahar E, Nieto FJ et al (2002) Predictors of sleep-disordered breathing in community-dwelling adults: The Sleep Heart Health Study. Arch Intern Med 162:893-900. doi: 10.1001/archinte.162.8.893
35. Lofaso F, Verschueren P, Rande JL, Harf A, Goldenberg F (1994) Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 106:1689-1694. doi: 10.1378/ chest.106.6.1689
36. Chan J, Sanderson J, Chan W et al (1997) Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 111:1488-1493. doi: 10.1378/ chest.111.6.1488
37. Tremel F, Pepin JL, Veale D et al (1999) High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20:1201-1209. doi: 10.1053/euhj.1999.1546
38. Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574-1579
39. CIBIS-II Investigators and Committe (1999) The cardiac insufficiency bisoprolol study II (CIBIS II): A randomised trial. Lancet 353:9-13. doi: 10.1016/S0140-6736(98)11181-9
40. MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001-2007. doi: 10.1016/ S0140-6736(99)04440-2
41. Packer M, Coats AJ, Fowler MB et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658. doi: 10.1056/NEJM200105313442201
42. Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P (2003) Central sleep apnea in left ventricular dysfunction: Prevalence and implications for arrhythmic risk. Circulation 107:727-732. doi: 10.1161/01.CIR.0000049641.11675.EE
43. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9:251-257. doi: 10.1016/j.ejheart.2006.08.003
44. Wang H, Parker JD, Newton GE et al (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49:1625-1631. doi: 10.1016/j.jacc.2006.12.046
45. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 365:1046-1053
46. Hung J, Whitford EG, Parsons RW, Hillman DR (1990) Association of sleep apnoea with myocardial infarction in men. Lancet 336:261-264. doi: 10.1016/0140-6736(90)91799-G
47. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B (1999) Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 92:79-84. doi: 10.1159/000006952
48. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378-1384. doi: 10.1056/NEJM200005113421901
49. Alonso-Fernandez A, Garcia-Rio F, Racionero MA et al (2005) Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 127:15-22. doi: 10.1378/chest.127.1.15
50. Gami AS, Pressman G, Caples SM et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110:364-367. doi: 10.1161/01.CIR.0000136587.68725.8E
51. Mehra R, Benjamin EJ, Shahar E et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 173:910-916. doi: 10.1164/ rccm.200509-1442OC
52. Javaheri S, Shukla R, Zeigler H, Wexler L (2007) Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49:2028-2034. doi: 10.1016/j.jacc.2007.01.084
53. Dempsey JA (2005) Crossing the apnoeic threshold: Causes and consequences. Exp Physiol 90:13-24. doi: 10.1113/expphysiol.2004.028985
54. Javaheri S (1999) A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341:949-954. doi: 10.1056/NEJM199909233411304
55. Javaheri S (2005) Central sleep apnea in congestive heart failure: prevalence, mechanisms, impact, and therapeutic options. Semin Respir Crit Care Med 26:44-55. doi: 10.1055/s-2005-864206
56. White DP (2005) Pathogenesis of obstructive, central sleep apnea. Am J Respir Crit Care Med 172(11):1363-1370
57. Krimsky WR, Leiter JC (2005) Physiology of breathing and respiratory control during sleep. Semin Respir Crit Care Med 26:5-12. doi: 10.1055/ s-2005-864197
58. Fogel RB, Malhotra A, White DP (2004) Sleep. 2: Pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax 59:159-163. doi: 10.1136/thorax.2003.015859
59. Gibson GJ (2004) Obstructive sleep apnoea syndrome: Underestimated and undertreated. Br Med Bull 72:49-65. doi: 10.1093/bmb/ldh044
60. Oksenberg A, Khamaysi I, Silverberg DS, Tarasiuk A (2000) Association of body position with severity of apneic events in patients with severe nonpositional obstructive sleep apnea. Chest 118:1018-1024. doi: 10.1378/ chest.118.4.1018
61. De Backer WA (1995) Central sleep apnoea, pathogenesis and treatment: An overview and perspective. Eur Respir J 8:1372-1383. doi: 10.1183/ 09031936.95.08081372
62. Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, Bradley TD (1996) Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 154:376-381
63. Ryan CM, Bradley TD (2005) Periodicity of obstructive sleep apnea in patients with and without heart failure. Chest 127:536-542. doi: 10.1378/ chest.127.2.536
64. Bradley TD, Floras JS (2003) Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 107:1671-1678. doi: 10.1161/ 01.CIR.0000061757.12581.15
65. Bucca CB, Brussino L, Battisti A et al (2007) Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 132:440-446. doi: 10.1378/chest.07-0311
66. Lavie L (2003) Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 7:35-51. doi: 10.1053/smrv.2002.0261
67. Schulz R, Mahmoudi S, Hattar K et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570
68. Morrell MJ, Finn L, Kim H, Peppard PE, Badr MS, Young T (2000) Sleep fragmentation, awake blood pressure, and sleep-disordered breathing in a population-based study. Am J Respir Crit Care Med 162:2091-2096
69. Kato M, Roberts-Thomson P, Phillips BG et al (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102:2607-2610
70. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F (2002) Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165:67-70
71. Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462-2464. doi: 10.1161/01.CIR.0000018948.95175.03
72. Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W (2000) Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:648-652. doi: 10.1034/j.1399-3003.2000.16d14.x
73. Arnulf I, Merino-Andreu M, Perrier A, Birolleau S, Similowski T, Derenne JP (2002) Obstructive sleep apnea and venous thromboembolism. J Am Med Assoc 287:2655-2656. doi: 10.1001/jama.287.20.2655
74. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735-741. doi: 10.1016/ j.ehj.2004.02.021
75. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279:H234-H237
76. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897-1904. doi: 10.1172/JCI118235
77. Chattipakorn N, Incharoen T, Kanlop N, Chattipakorn S (2007) Heart rate variability in myocardial infarction and heart failure. Int J Cardiol 120:289-296. doi: 10.1016/j.ijcard.2006.11.221
78. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD (1994) Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 90:234-240
79. Notarius CF, Floras JS (2001) Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure. Europace 3:29-38. doi: 10.1053/ eupc.2000.0136
80. Chwan Ng AC, Freedman SB, Sindone AP (2007) Autonomic abnormalities in congestive heart failure patients with sleep-disordered breathing. J Card Fail 13:395-400. doi: 10.1016/j.cardfail.2007.02.003
81. Chen L, Shi Q, Scharf SM (2000) Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 88:1051-1060
82. Bradley TD, Hall MJ, Ando S, Floras JS (2001) Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 119:1827-1835. doi: 10.1378/chest.119.6.1827
83. Bradley TD, Tkacova R, Hall MJ, Ando S, Floras JS (2003) Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. Clin Sci (Lond), 104:231-238. doi: 10.1042/CS20020157
84. Spaak J, Egri ZJ, Kubo T et al (2005) Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 46:1327-1332. doi: 10.1161/01.HYP.0000193497.45200.66
85. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J (2005) Obstructive sleep apnea syndrome affects left ventricular diastolic function: Effects of nasal continuous positive airway pressure in men. Circulation 112:375-383. doi: 10.1161/ CIRCULATIONAHA.104.501841
86. Yin WH, Chen JW, Jen HL et al (2004) Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 147:931-938. doi: 10.1016/j.ahj.2003.11.021
87. Solin P, Kaye DM, Little PJ, Bergin P, Richardson M, Naughton MT (2003) Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123:1119-1126. doi: 10.1378/chest.123.4.1119
88. Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. BMJ (Clinical Research Ed.) 330:625. doi: 10.1136/bmj.330.7492.625
89. Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sanchez-Armengol A, Martinez-Martinez A, Capote F (2005) Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest 127:1667-1673. doi: 10.1378/chest.127.5.1667
90. Christ M, Sharkova Y, Fenske H et al (2007) Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients. Int J Cardiol 116:62-69. doi: 10.1016/j.ijcard.2006.03.031
91. Javaheri S (2006) Acetazolamide improves central sleep apnea in heart failure: A double-blind, prospective study. Am J Respir Crit Care Med 173:234-237. doi: 10.1164/rccm.200507-1035OC
92. Usui K, Bradley TD, Spaak J et al (2005) Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45:2008-2011. doi: 10.1016/j.jacc.2004.12.080
93. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169:361-366. doi: 10.1164/rccm.200306-752OC
94. Gilman MP, Floras JS, Usui K, Kaneko Y, Leung RS, Bradley TD (2008) Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 114:243-249. doi: 10.1042/CS20070172
95. Hunt SA, Abraham WT, Chin MH et al (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article: A report of the American College of Cardiology/ American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112:1825-1852. doi: 10.1161/CIRCULATIONAHA.105.167587
96. Sin DD, Fitzgerald F, Parker JD et al (2003) Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 123:1536-1543. doi: 10.1378/chest.123.5.1536
97. Kaneko Y, Floras JS, Usui K et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233-1241
98. Tkacova R, Dajani HR, Rankin F, Fitzgerald FS, Floras JS, Bradley TD (2000) Continuous positive airway pressure improves nocturnal baroreflex sensitivity of patients with heart failure and obstructive sleep apnea. J Hypertens 18:1257-1262. doi: 10.1097/00004872-200018090-00012
99. Yoshinaga K, Burwash IG, Leech JA et al (2007) The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol 49:450-458. doi: 10.1016/j.jacc.2006.08.059
100. McKie PM, Burnett JC Jr (2005) B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities. Mayo Clin Proc 80:1029-1036
101. Svatikova A, Shamsuzzaman AS, Wolk R, Phillips BG, Olson LJ, Somers VK (2004) Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol 94:529-532. doi: 10.1016/j.amjcard.2004.05.010
102. Smith LA, Vennelle M, Gardner RS et al (2007) Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: A randomized placebo-controlled trial. Eur Heart J 28:1221-1227. doi: 10.1093/eurheartj/ehm131
103. Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539-1549. doi: 10.1056/NEJMoa050496
104. Stanchina ML, Ellison K, Malhotra A et al (2007) The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: A pilot study. Chest 132:433-439. doi: 10.1378/chest.06-2509
105. Oldenburg O, Faber L, Vogt J et al (2007) Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 9:820-826. doi: 10.1016/j.ejheart.2007.03.009
106. Granton JT, Naughton MT, Benard DC, Liu PP, Goldstein RS, Bradley TD (1996) CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 153:277-282
107. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD (2000) Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102:61-66
108. Kasai T., Narui K., Dohi T et al (2005). Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with Cheyne-Stokes respiration and central sleep apnea. Circ J 69:913-921. doi: 10.1253/circj.69.913
109. Pepperell JC, Maskell NA, Jones DR et al (2003) A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168:1109-1114. doi: 10.1164/ rccm.200212-1476OC
110. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA (1996) Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 335:562-567. doi: 10.1056/NEJM199608223350805
111. Andreas S, Reiter H, Luthje L et al (2004) Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure. Circulation 110:2157-2162. doi: 10.1161/ 01.CIR.0000144356.39262.16
112. Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H (2006) Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J 70:1-7. doi: 10.1253/ circj.70.1